Annual report pursuant to section 13 and 15(d)

Note 12 - Subsequent Events (Details)

v2.4.0.8
Note 12 - Subsequent Events (Details) (USD $)
 1 Months Ended 12 Months Ended 1 Months Ended
Jan. 31, 2013
Jul. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Nov. 30, 2010
Mar. 31, 2014
Subsequent Event [Member]
The 2014 Notes Offering [Member]
Mar. 31, 2014
Subsequent Event [Member]
Issued to Placement Agents and Subagents [Member]
Mar. 31, 2014
Subsequent Event [Member]
Investment from Non-employee Directors [Member]
Mar. 31, 2014
Subsequent Event [Member]
Boston Scientific Notes [Member]
Mar. 31, 2014
Subsequent Event [Member]
The 2014 Notes Offering [Member]
Mar. 31, 2014
Subsequent Event [Member]
Transferred Intellectual Property [Member]
Mar. 31, 2014
Subsequent Event [Member]
Jan. 31, 2013
Investment from Non-employee Directors [Member]
Jul. 31, 2012
Investment from Non-employee Directors [Member]
Note 12 - Subsequent Events (Details) [Line Items]                              
Sale of Intangible Assets, Sale Price                       $ 4,338,601      
Notes Payable Cancelled, Principal Amount                   4,338,601          
Debt Instrument, Interest Rate, Stated Percentage           3.50%         12.00%        
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in Shares)                     0.3        
Proceeds from Secured Notes Payable                     3,625,000        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)             1,087,500 69,750              
Proceeds from Issuance of Private Placement 9,829,014 5,516,495 9,829,014 5,516,495         1,100,000   3,625,000   3,400,000 402,000 269,980
Debt Issuance Cost                     80,000        
Debt Instrument, Term                     5 years        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item) 1.20 1.10 1.33 0.95 0.43           1.75        
Payments for Commissions $ 1,104,202             $ 139,500